Cargando…
The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708708/ https://www.ncbi.nlm.nih.gov/pubmed/31145332 http://dx.doi.org/10.1097/MD.0000000000015844 |
_version_ | 1783446052131569664 |
---|---|
author | Shi, Xin Zheng, Yanhua Xu, Li Cao, Chun Dong, Baoxia Chen, Xiequn |
author_facet | Shi, Xin Zheng, Yanhua Xu, Li Cao, Chun Dong, Baoxia Chen, Xiequn |
author_sort | Shi, Xin |
collection | PubMed |
description | BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, have yielded controversial results. Thus, we performed a meta-analysis to assess the levels of these inflammatory cytokines in MDS. METHODS: A systematic search in PubMed, MEDLINE, Cochrane Library, Web of Science, CNKI, and CBM was conducted to find eligible studies. Meta-analyses were performed using STATA 12.0 for Windows. Heterogeneity between included studies was assessed by I(2) test. We chose SMD as the summary statistic. RESULTS: A total of 697 individuals from 11 studies were included in this study. Our results suggest the levels of TNF-α, IL-6, IL-8 were significantly higher in MDS patients compared with controls, SMD and 95%CI was 1.48 (0.60, 2.36), 0.71 (0.16, 1.25) and 0.69 (0.28, 1.09), respectively. Moreover, the levels of IL-17 have decreased in the high-risk MDS, the SMD and 95% CI was 2.96 (0.78, 5.15). CONCLUSION: A close association between immunological microenvironment disorders and the pathogenesis of MDS was revealed in this meta-analysis. More importantly, the profiles of inflammatory cytokines appear to change along the progression of the disease. |
format | Online Article Text |
id | pubmed-6708708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-67087082019-10-01 The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis Shi, Xin Zheng, Yanhua Xu, Li Cao, Chun Dong, Baoxia Chen, Xiequn Medicine (Baltimore) Research Article BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, have yielded controversial results. Thus, we performed a meta-analysis to assess the levels of these inflammatory cytokines in MDS. METHODS: A systematic search in PubMed, MEDLINE, Cochrane Library, Web of Science, CNKI, and CBM was conducted to find eligible studies. Meta-analyses were performed using STATA 12.0 for Windows. Heterogeneity between included studies was assessed by I(2) test. We chose SMD as the summary statistic. RESULTS: A total of 697 individuals from 11 studies were included in this study. Our results suggest the levels of TNF-α, IL-6, IL-8 were significantly higher in MDS patients compared with controls, SMD and 95%CI was 1.48 (0.60, 2.36), 0.71 (0.16, 1.25) and 0.69 (0.28, 1.09), respectively. Moreover, the levels of IL-17 have decreased in the high-risk MDS, the SMD and 95% CI was 2.96 (0.78, 5.15). CONCLUSION: A close association between immunological microenvironment disorders and the pathogenesis of MDS was revealed in this meta-analysis. More importantly, the profiles of inflammatory cytokines appear to change along the progression of the disease. Wolters Kluwer Health 2019-05-31 /pmc/articles/PMC6708708/ /pubmed/31145332 http://dx.doi.org/10.1097/MD.0000000000015844 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Shi, Xin Zheng, Yanhua Xu, Li Cao, Chun Dong, Baoxia Chen, Xiequn The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title | The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title_full | The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title_fullStr | The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title_full_unstemmed | The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title_short | The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis |
title_sort | inflammatory cytokine profile of myelodysplastic syndromes: a meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708708/ https://www.ncbi.nlm.nih.gov/pubmed/31145332 http://dx.doi.org/10.1097/MD.0000000000015844 |
work_keys_str_mv | AT shixin theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT zhengyanhua theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT xuli theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT caochun theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT dongbaoxia theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT chenxiequn theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT shixin inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT zhengyanhua inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT xuli inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT caochun inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT dongbaoxia inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis AT chenxiequn inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis |